Innoviva Inc

NASDAQ:INVA   3:59:06 PM EDT
12.52
+0.22 (+1.79%)
Twitter Share  Facebook Share StockTwits Share

Search For a Symbol

Market Cap (Intraday)1.29B
Current PE4.67
Forward PE 5.69
2yr Forward PE 7.32
See more stats
Estimates Current Quarter
Revenue$75.3 Million
Adjusted EPS$0.41
See more estimates
10-Day MA$12.48
50-Day MA$11.69
200-Day MA$12.37
See more pivots

Innoviva, Inc. Stock, NASDAQ:INVA

2000 SIERRA POINT PARKWAY, SUITE 500, BRISBANE, CA 94005
United States of America
Phone: 6502389600
Number of Employees: 6
www.inva.com

Description

Theravance, Inc., a royalty management company, is focused on developing respiratory products. It receives royalty revenues RELVAR/BREO ELLIPTA (fluticasone furoate/vilanterol, FF/VI), ANORO ELLIPTA (umeclidinium bromide/vilanterol, UMEC/VI), and ...